← Leaderboards
John Nagi Kheir
Boston Children'S Hospital
$4,394,281
Attributed
$6,476,035
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,476,035 · 5
By mechanism
R33$2,366,065 · 1
R01$2,344,497 · 1
R42$1,036,191 · 1
R61$410,558 · 1
R43$318,724 · 1
Top collaborators
- Lynn A Sleeper4 shared
- Brian David Polizzotti2 shared
- Daryoosh Vakhshoori1 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Catherine Ross$1,300,095
- Brian David Polizzotti$757,024
- Ben Adam Croker$3,608,646
Others in their field
Other Emerging Leaders on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Research focus
LeadOxygenDeprivationSafetyImpairmentCellular StructuresNervous System TraumaFamily SuidaeHeart ArrestHypoxemiaInjuryIschemiaBrainRodentAdverse EffectsNeurologicGasesEnsureDevicesManualsBostonFeedbackEnvironmentCritical Illness
Grant awards (10)
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$802,141
R33 · FY2025 · HL · contact PI
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$768,213
R33 · FY2024 · HL · contact PI
Monitoring of Oxygen Delivery and Tissue Oxygenation Deprivation in Critically Ill Neonates Using Resonance Raman Spectroscopy$318,724
R43 · FY2024 · HD
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$795,711
R33 · FY2023 · HL · contact PI
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR$410,558
R61 · FY2022 · HL · contact PI
SnapCap: a device to decontaminate central venous catheters (CVC) with 5 snaps$1,036,191
R42 · FY2021 · HD · contact PI
Intravenous oxygen microparticles for treatment of cardiac arrest$611,952
R01 · FY2021 · HL · contact PI
Intravenous oxygen microparticles for treatment of cardiac arrest$664,383
R01 · FY2020 · HL · contact PI
Intravenous oxygen microparticles for treatment of cardiac arrest$596,114
R01 · FY2019 · HL
Intravenous oxygen microparticles for treatment of cardiac arrest$472,048
R01 · FY2018 · HL